Trinity Biotech Announces Successful Clinical Test Results For New Prostate Cancer Test AI-Incorporated Algorithm

Trinity Biotech announced successful clinical test results for its upgraded prostate cancer test, which utilized an AI-incorporated algorithm. The evaluation was based on a comprehensive study involving around 750 patient samples, providing a more diverse cohort compared to previous studies. The independent validation was conducted by a specialist bioinformatics research partner to ensure the diagnostic performance of the next-generation EpiCapture™ algorithm.